{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "Flavivirus antigens", "item": "https://www.patentleaderboard.com/patent/7476390"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Flavivirus antigens

Flavivirus antigens

US Patent 7476390 · Granted Jan 13, 2009

Estimated economic value: $7,049,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-cancer combination therapies comprising CTLA-4 and PD-1 blocking agents2025
CTLA4 binders2023
PD1/CTLA4 binders2020
CTLA4 binders2019
Substituted triazolo-pyrimidine compounds for modulating cell proliferation, dif2017
Recombinant dengue virus antigen comprising the capsid protein leader sequence, 2015
Recombinant dengue virus antigen comprising the capsid protein leader sequence, 2015
Recombinant dengue virus antigen comprising the capsid protein leader sequence, 2015
Substituted triazolo-pyrimidine compounds for modulating cell proliferation dif2015
Recombinant dengue virus antigen comprising the capsid protein leader sequence, 2014
Recombinant dengue virus antigen comprising the capsid protein leader sequence, 2014
Recombinant dengue virus antigen comprising the capsid protein leader sequence, 2014